Literature DB >> 18272594

BMP type I receptor complexes have distinct activities mediating cell fate and axon guidance decisions.

Ken Yamauchi1, Keith D Phan, Samantha J Butler.   

Abstract

The finding that morphogens, signalling molecules that specify cell identity, also act as axon guidance molecules has raised the possibility that the mechanisms that establish neural cell fate are also used to assemble neuronal circuits. It remains unresolved, however, how cells differentially transduce the cell fate specification and guidance activities of morphogens. To address this question, we have examined the mechanism by which the Bone morphogenetic proteins (BMPs) guide commissural axons in the developing spinal cord. In contrast to studies that have suggested that morphogens direct axon guidance decisions using non-canonical signal transduction factors, our results indicate that canonical components of the BMP signalling pathway, the type I BMP receptors (BMPRs), are both necessary and sufficient to specify the fate of commissural neurons and guide their axonal projections. However, whereas the induction of cell fate is a shared property of both type I BMPRs, axon guidance is chiefly mediated by only one of the type I BMPRs, BMPRIB. Taken together, these results indicate that the diverse activities of BMP morphogens can be accounted for by the differential use of distinct components of the canonical BMPR complex.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18272594     DOI: 10.1242/dev.012989

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  42 in total

Review 1.  Navigating intermediate targets: the nervous system midline.

Authors:  Barry J Dickson; Yimin Zou
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-06-09       Impact factor: 10.005

Review 2.  Mechanisms and molecules of neuronal wiring: a primer.

Authors:  Alex L Kolodkin; Marc Tessier-Lavigne
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-06-01       Impact factor: 10.005

3.  Canonical BMP-Smad signalling promotes neurite growth in rat midbrain dopaminergic neurons.

Authors:  Shane V Hegarty; Louise M Collins; Aisling M Gavin; Sarah L Roche; Sean L Wyatt; Aideen M Sullivan; Gerard W O'Keeffe
Journal:  Neuromolecular Med       Date:  2014-03-29       Impact factor: 3.843

4.  Smad4 is required predominantly in the developmental processes dependent on the BMP branch of the TGF-β signaling system in the embryonic mouse retina.

Authors:  Deepa Murali; Motoko Kawaguchi-Niida; Chu-Xia Deng; Yasuhide Furuta
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-05-02       Impact factor: 4.799

5.  Diverse spinal commissural neuron populations revealed by fate mapping and molecular profiling using a novel Robo3Cre mouse.

Authors:  Alastair J Tulloch; Shaun Teo; Brigett V Carvajal; Marc Tessier-Lavigne; Alexander Jaworski
Journal:  J Comp Neurol       Date:  2019-06-14       Impact factor: 3.215

6.  Type Ib BMP receptors mediate the rate of commissural axon extension through inhibition of cofilin activity.

Authors:  Ken Yamauchi; Supraja G Varadarajan; Joseph E Li; Samantha J Butler
Journal:  Development       Date:  2013-01-15       Impact factor: 6.868

Review 7.  The multiple activities of BMPs during spinal cord development.

Authors:  Gwenvael Le Dréau; Elisa Martí
Journal:  Cell Mol Life Sci       Date:  2013-05-15       Impact factor: 9.261

8.  Assaying the ability of diffusible signaling molecules to reorient embryonic spinal commissural axons.

Authors:  Virginia M Hazen; Keith Phan; Ken Yamauchi; Samantha J Butler
Journal:  J Vis Exp       Date:  2010-03-08       Impact factor: 1.355

Review 9.  Axon guidance at the midline: of mice and flies.

Authors:  Timothy A Evans; Greg J Bashaw
Journal:  Curr Opin Neurobiol       Date:  2010-01-14       Impact factor: 6.627

10.  ActRIIA and BMPRII Type II BMP receptor subunits selectively required for Smad4-independent BMP7-evoked chemotaxis.

Authors:  Jeanette C Perron; Jane Dodd
Journal:  PLoS One       Date:  2009-12-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.